日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Comparison of the Efficacy and Safety between Adjuvant and Palliative Anti-PD-1 Treatment of Stage 4 Oligometastatic Melanoma

比较辅助性抗PD-1治疗和姑息性抗PD-1治疗在IV期寡转移性黑色素瘤中的疗效和安全性

期刊:Dermatology Practical & Conceptual
影响因子:2.3
doi:10.5826/dpc.1601a6483
Pásek, Marek; Arenberger, Petr; Tretera, Vojtěch; Palkovský, Martin; Vránová, Jana; Arenbergerová, Monika
PD-1
黑色素瘤
发表日期：2026
文献求助 收藏

Prognostic Biomarkers for Anti-PD-1 Monoclonal Antibodies in the First Line Treatment of Advanced Melanoma

抗PD-1单克隆抗体一线治疗晚期黑色素瘤的预后生物标志物

期刊:International Journal of Dermatology
影响因子:3.2
doi:10.1111/ijd.17842
Pásek, Marek; Marques, Emanuel; Tretera, Vojtěch; Arenberger, Petr; Arenbergerová, Monika; Šilar, Jiří; Šulc, David
单克隆抗体
黑色素瘤
PD-1
发表日期：2025
文献求助 收藏

The outcome in patients with BRAF-mutated metastatic melanoma treated with anti-programmed death receptor-1 monotherapy or targeted therapy in the real-world setting

在真实世界中，接受抗程序性死亡受体-1单药治疗或靶向治疗的BRAF突变转移性黑色素瘤患者的预后

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.6982
Kopecký, Jindřich; Pásek, Marek; Lakomý, Radek; Melichar, Bohuslav; Mrazová, Ivona; Kubeček, Ondřej; Arenbergerová, Monika; Lemstrová, Radmila; Švancarová, Alžběta; Tretera, Vojtěch; Hlodáková, Alžběta; Žváčková, Kamila
黑色素瘤
信号转导
BRAF
发表日期：2024
文献求助 收藏